NB
RMD icon

NBT Bank’s ResMed RMD Stock Holding History

NBT Bank’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.4K Buy
220
+15
+7% +$3.74K ﹤0.01% 505
2025
Q4 		$49.4K Sell
205
-47
-19% -$12K ﹤0.01% 499
2025
Q3 		$69K Buy
252
+47
+23% +$12.8K ﹤0.01% 469
2025
Q2 		$52.9K Hold
205
– – ﹤0.01% 495
2025
Q1 		$45.9K Hold
205
– – ﹤0.01% 502
2024
Q4 		$46.9K Hold
205
– – ﹤0.01% 507
2024
Q3 		$50K Buy
+205
New +$45.8K ﹤0.01% 523

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NBT Bank's RMD Position: Q1 2026 in Review

NBT Bank increased its ResMed (RMD) stake by 7.3% in Q1 2026, buying an estimated $3.74K and bringing the position to 220 shares worth $49.4K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

NBT Bank first reported a position in RMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $69K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • NBT Bank held 220 shares of ResMed worth $49.4K as of Q1 2026.
  • NBT Bank bought 15 ResMed shares in Q1 2026, an estimated $3.74K.
  • ResMed made up ﹤0.01% of NBT Bank's portfolio in Q1 2026, its #505 holding.
  • NBT Bank first reported a position in ResMed in Q3 2024 and has held it in 7 quarters since.
  • NBT Bank's ResMed position peaked at $69K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.